Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $18,282.88 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 5,936 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $3.08, for a total value of $18,282.88. Following the transaction, the insider now owns 85,445 shares of the company’s stock, valued at approximately $263,170.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Cardlytics Trading Up 7.5 %

Shares of NASDAQ:CDLX opened at $3.29 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $160.50 million, a price-to-earnings ratio of -0.74 and a beta of 1.67. Cardlytics, Inc. has a 1-year low of $2.89 and a 1-year high of $20.52. The company has a 50 day moving average price of $4.24 and a 200 day moving average price of $8.41.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.12. The business had revenue of $69.64 million during the quarter, compared to analyst estimates of $75.39 million. Cardlytics had a negative return on equity of 17.96% and a negative net margin of 50.21%. The company’s revenue was down 9.2% compared to the same quarter last year. During the same period last year, the company posted ($0.57) EPS. On average, research analysts anticipate that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.

Hedge Funds Weigh In On Cardlytics

A number of institutional investors have recently bought and sold shares of CDLX. SG Americas Securities LLC purchased a new stake in Cardlytics during the third quarter valued at about $45,000. Marshall Wace LLP raised its holdings in shares of Cardlytics by 6.8% during the second quarter. Marshall Wace LLP now owns 814,281 shares of the company’s stock valued at $6,685,000 after acquiring an additional 52,081 shares during the period. XTX Topco Ltd purchased a new stake in shares of Cardlytics in the 2nd quarter valued at approximately $107,000. Pekin Hardy Strauss Inc. acquired a new position in Cardlytics in the 2nd quarter worth approximately $243,000. Finally, Renaissance Technologies LLC boosted its stake in Cardlytics by 711.9% in the 2nd quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock worth $2,882,000 after purchasing an additional 307,800 shares during the period. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CDLX shares. Northland Securities downgraded Cardlytics from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $7.00 to $5.00 in a research report on Friday, August 16th. Northland Capmk downgraded Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Craig Hallum downgraded Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. Bank of America cut Cardlytics from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. Finally, Needham & Company LLC lowered Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $7.50.

Read Our Latest Analysis on Cardlytics

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.